HANISH ARNOLD C — SEC insider filings
SEC reporting owner CIK 1233253. 23 insider filings on record with FilingPulse; latest filed 2026-09-02.
Transaction summary — filings shown
Covers all 23 filings on record, filed 2020-08-24 to 2026-09-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 7 legs across 7 filings — 55,350 shares, $38,672 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 6 legs across 3 filings — 20,027 shares, $314,411 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
- Largest priced transaction: sale of 5,000 shares @ $19.02 ($95,081) in OMEROS CORP, filed 2026-08-28.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| OMEROS CORP (OMER) | Director | 10 | — | 4 legs · 20,000 sh · $314,394 | 17 |
| Decoy Therapeutics Inc. (DCOY) | Director | 13 | 7 legs · 55,350 sh · $38,672 | 2 legs · 27 sh · $17 | 5 |
Insider filings — HANISH ARNOLD C
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-02 | 4 | Decoy Therapeutics Inc. (DCOY) | Grant/award (A): 3,000 @ $0 | EDGAR |
| 2026-08-28 | 4 | OMEROS CORP (OMER) | Option exercise (M): 5,000 @ $15.81 · Sale (S): 5,000 @ $18.53 · Option exercise (M): 2,500 @ $15.81 · Option exercise (M): 7,500 @ $14.66 · Sale (S): 5,000 @ $18.88 · Sale (S): 5,000 @ $19.02 · +3 more | EDGAR |
| 2026-06-22 | 4 | OMEROS CORP (OMER) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2026-01-02 | 4 | Salarius Pharmaceuticals, Inc. (SLRX) | Sale (S): 15 @ $0.64 · Sale (S): 12 @ $0.64 | EDGAR |
| 2025-11-24 | 4 | Salarius Pharmaceuticals, Inc. (SLRX) | Purchase (P): 5,000 @ $0.75 | EDGAR |
| 2025-07-01 | 4 | OMEROS CORP (OMER) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | OMEROS CORP (OMER) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2024-02-22 | 4 | Salarius Pharmaceuticals, Inc. (SLRX) | Grant/award (A): 20,500 (derivative) @ $0 | EDGAR |
| 2023-06-27 | 4 | OMEROS CORP (OMER) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2023-05-23 | 4 | OMEROS CORP (OMER) | Option exercise (M): 5,000 @ $5.30 · Sale (S): 5,000 @ $6.46 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2023-01-05 | 4 | Salarius Pharmaceuticals, Inc. (SLRX) | Grant/award (A): 1,440 @ $0 | EDGAR |
| 2022-09-23 | 4 | OMEROS CORP (OMER) | Grant/award (A): 7,500 (derivative) @ $0 | EDGAR |
| 2022-06-22 | 4 | OMEROS CORP (OMER) | Grant/award (A): 7,500 (derivative) @ $0 | EDGAR |
| 2022-06-06 | 4/A | Salarius Pharmaceuticals, Inc. (SLRX) | Purchase (P): 3,000 @ $3.59 | EDGAR |
| 2022-06-06 | 4/A | Salarius Pharmaceuticals, Inc. (SLRX) | Purchase (P): 4,350 @ $1.15 | EDGAR |
| 2022-06-06 | 4/A | Salarius Pharmaceuticals, Inc. (SLRX) | Purchase (P): 4,000 @ $0.98 | EDGAR |
| 2022-06-06 | 4 | Salarius Pharmaceuticals, Inc. (SLRX) | Purchase (P): 28,000 @ $0.18 | EDGAR |
| 2022-02-14 | 4 | OMEROS CORP (OMER) | Grant/award (A): 7,500 (derivative) @ $0 | EDGAR |
| 2022-01-21 | 4 | Salarius Pharmaceuticals, Inc. (SLRX) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2021-09-09 | 4 | OMEROS CORP (OMER) | Option exercise (M): 10,000 @ $9.44 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2021-08-11 | 4 | Salarius Pharmaceuticals, Inc. (SLRX) | Purchase (P): 7,000 @ $0.88 | EDGAR |
| 2020-12-04 | 4 | Salarius Pharmaceuticals, Inc. (SLRX) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2020-08-24 | 4 | Salarius Pharmaceuticals, Inc. (SLRX) | Purchase (P): 4,000 @ $0.98 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1233253 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs